Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2015-02-02 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
内部控制规则落实自查表
Audit Report / Information Classification · 90% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to audit committee operations, information disclosure, insider trading controls, fundraising controls, related party transactions, guarantees, major investments, and other important matters. The document is a self-assessment or internal control checklist rather than a formal audit report or annual report. It does not contain financial statements or substantive financial data but focuses on internal control compliance and procedures. The length is 4324 characters, which is relatively short and the content is more of an internal control compliance report rather than a standalone audit report or annual report. This type of document fits best under Audit Report / Information (AR) as it relates to internal audit and control rules implementation and self-assessment, which is consistent with the description of standalone audit reports and applied accounting principles or internal control results, excluding full annual reports. FY 2014
2015-02-02 Chinese
独立董事关于相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent director's opinion on various company matters for the year 2014, including related party fund occupation, external guarantees, profit distribution plan, fundraising usage, and internal control evaluation. It references compliance with regulatory guidelines and company rules but does not contain full financial statements or detailed financial data. The document is a formal opinion or certification by independent directors rather than a full annual report or audit report. It is also relatively short (2017 characters) and does not present comprehensive financial results or management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which covers attestations, certifications, and miscellaneous regulatory documents that do not fit other categories.
2015-02-02 Chinese
2014年年度报告
Annual Report Classification · 100% confidence The document is titled '2014 年年度报告全文' which translates to '2014 Annual Report Full Text'. It contains detailed sections typical of an annual report, including company overview, financial data and indicators, board of directors report, risk disclosures, accounting policies, financial statements, and other comprehensive information. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes detailed financial data, management discussion, and analysis, which are characteristic of an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2014
2015-02-02 Chinese
第二届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangdong Taicheng Pharmaceutical Co., Ltd. It discusses the approval of the 2014 Supervisory Board Work Report, the 2014 Financial Final Accounts Report, the 2014 Profit Distribution Proposal, the 2014 Annual Report and its summary, the 2014 Internal Control Self-Evaluation Report, and the 2014 Special Report on the Use of Raised Funds. The document states these reports will be submitted to the shareholders' meeting for approval. The document itself is a meeting resolution announcement and does not contain the full annual report or detailed financial statements. The document length is short (1553 characters) and it references that the full reports are available elsewhere (e.g., on the CNINFO website). Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of supervisory board resolutions and report approvals, not the full Annual Report (10-K) or other detailed financial reports.
2015-02-02 Chinese
关于第二届董事会第二十一次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at a board of directors meeting of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes voting results on various reports such as the 2014 Board Work Report, General Manager's Work Report, 2014 Financial Final Accounts Report, Profit Distribution Plan, and other internal control and fundraising reports. The document also mentions that these reports will be submitted to the shareholders' meeting for approval. The document is not the full annual report or financial statements but rather a formal announcement of board meeting decisions and voting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board. The document length is 3219 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2015-02-02 Chinese
2014年年度审计报告
Regulatory Filings
2015-02-02 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.